Replies to post #36386 on Anavex Life Sciences Corp (AVXL)

[stealthways]

Besides Europe (the biggest sales in-licence opportunity) the following marketing in-licence deals are also available to fund operations and P3 trials , without dilution, Japan might be interesting because of its aging population and huge healthcare costs caring for elderly) and Otsuka might be interested in a simple home country marketing deal:

-Japan
-Asia (non-japan)
-other common wealth countries (UK,Aus,CAD)
-Latin America


Note with in-licencing deals AVXL is still the operator of world wide manufacturing and controls all rights, all that is sold is distributor rights for specific areas, which are need anyways.